vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and CSW INDUSTRIALS, INC. (CSW). Click either name above to swap in a different company.
CSW INDUSTRIALS, INC. is the larger business by last-quarter revenue ($233.0M vs $196.0M, roughly 1.2× Axsome Therapeutics, Inc.). CSW INDUSTRIALS, INC. runs the higher net margin — 4.4% vs -14.6%, a 19.0% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 20.3%). CSW INDUSTRIALS, INC. produced more free cash flow last quarter ($22.7M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 5.1%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
AXSM vs CSW — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $233.0M |
| Net Profit | $-28.6M | $10.3M |
| Gross Margin | — | 39.7% |
| Operating Margin | -13.8% | 7.4% |
| Net Margin | -14.6% | 4.4% |
| Revenue YoY | 65.0% | 20.3% |
| Net Profit YoY | 61.9% | -61.9% |
| EPS (diluted) | $-0.55 | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $233.0M | ||
| Q3 25 | $171.0M | $277.0M | ||
| Q2 25 | $150.0M | $263.6M | ||
| Q1 25 | $121.5M | $230.5M | ||
| Q4 24 | $118.8M | $193.6M | ||
| Q3 24 | $104.8M | $227.9M | ||
| Q2 24 | $87.2M | $226.2M | ||
| Q1 24 | $75.0M | $210.9M |
| Q4 25 | $-28.6M | $10.3M | ||
| Q3 25 | $-47.2M | $40.7M | ||
| Q2 25 | $-48.0M | $40.9M | ||
| Q1 25 | $-59.4M | $35.1M | ||
| Q4 24 | $-74.9M | $26.9M | ||
| Q3 24 | $-64.6M | $36.1M | ||
| Q2 24 | $-79.3M | $38.6M | ||
| Q1 24 | $-68.4M | $31.8M |
| Q4 25 | — | 39.7% | ||
| Q3 25 | — | 43.0% | ||
| Q2 25 | — | 43.8% | ||
| Q1 25 | — | 44.2% | ||
| Q4 24 | — | 41.4% | ||
| Q3 24 | — | 45.6% | ||
| Q2 24 | — | 47.5% | ||
| Q1 24 | — | 44.4% |
| Q4 25 | -13.8% | 7.4% | ||
| Q3 25 | -27.0% | 20.5% | ||
| Q2 25 | -24.5% | 20.8% | ||
| Q1 25 | -46.9% | 19.5% | ||
| Q4 24 | -61.1% | 15.3% | ||
| Q3 24 | -59.8% | 22.6% | ||
| Q2 24 | -89.5% | 24.3% | ||
| Q1 24 | -89.7% | 21.0% |
| Q4 25 | -14.6% | 4.4% | ||
| Q3 25 | -27.6% | 14.7% | ||
| Q2 25 | -32.0% | 15.5% | ||
| Q1 25 | -48.9% | 15.2% | ||
| Q4 24 | -63.1% | 13.9% | ||
| Q3 24 | -61.7% | 15.8% | ||
| Q2 24 | -91.0% | 17.1% | ||
| Q1 24 | -91.1% | 15.1% |
| Q4 25 | $-0.55 | $0.62 | ||
| Q3 25 | $-0.94 | $2.41 | ||
| Q2 25 | $-0.97 | $2.43 | ||
| Q1 25 | $-1.22 | $2.05 | ||
| Q4 24 | $-1.54 | $1.60 | ||
| Q3 24 | $-1.34 | $2.26 | ||
| Q2 24 | $-1.67 | $2.47 | ||
| Q1 24 | $-1.44 | $2.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $40.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $1.1B |
| Total Assets | $689.8M | $2.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $40.2M | ||
| Q3 25 | $325.3M | $31.5M | ||
| Q2 25 | $303.0M | $38.0M | ||
| Q1 25 | $300.9M | $225.8M | ||
| Q4 24 | $315.4M | $213.8M | ||
| Q3 24 | $327.3M | $273.2M | ||
| Q2 24 | $315.7M | $18.9M | ||
| Q1 24 | $331.4M | $22.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $800.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $166.0M |
| Q4 25 | $88.3M | $1.1B | ||
| Q3 25 | $73.7M | $1.1B | ||
| Q2 25 | $73.1M | $1.1B | ||
| Q1 25 | $53.2M | $1.1B | ||
| Q4 24 | $57.0M | $1.0B | ||
| Q3 24 | $92.9M | $1.0B | ||
| Q2 24 | $102.9M | $650.2M | ||
| Q1 24 | $144.0M | $615.7M |
| Q4 25 | $689.8M | $2.3B | ||
| Q3 25 | $669.3M | $1.5B | ||
| Q2 25 | $639.8M | $1.5B | ||
| Q1 25 | $596.7M | $1.4B | ||
| Q4 24 | $568.5M | $1.4B | ||
| Q3 24 | $561.5M | $1.4B | ||
| Q2 24 | $548.2M | $1.1B | ||
| Q1 24 | $545.7M | $1.0B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $28.9M |
| Free Cash FlowOCF − Capex | $-18.7M | $22.7M |
| FCF MarginFCF / Revenue | -9.6% | 9.8% |
| Capex IntensityCapex / Revenue | 0.0% | 2.6% |
| Cash ConversionOCF / Net Profit | — | 2.81× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $162.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $28.9M | ||
| Q3 25 | $1.0M | $61.8M | ||
| Q2 25 | $-32.4M | $60.6M | ||
| Q1 25 | $-43.4M | $27.3M | ||
| Q4 24 | $-26.2M | $11.6M | ||
| Q3 24 | $-18.6M | $66.8M | ||
| Q2 24 | $-30.1M | $62.7M | ||
| Q1 24 | $-53.5M | $22.4M |
| Q4 25 | $-18.7M | $22.7M | ||
| Q3 25 | $988.0K | $58.7M | ||
| Q2 25 | $-32.4M | $57.7M | ||
| Q1 25 | $-43.7M | $22.8M | ||
| Q4 24 | $-26.2M | $8.5M | ||
| Q3 24 | $-18.7M | $61.3M | ||
| Q2 24 | $-30.2M | $59.6M | ||
| Q1 24 | $-53.6M | $17.5M |
| Q4 25 | -9.6% | 9.8% | ||
| Q3 25 | 0.6% | 21.2% | ||
| Q2 25 | -21.6% | 21.9% | ||
| Q1 25 | -36.0% | 9.9% | ||
| Q4 24 | -22.1% | 4.4% | ||
| Q3 24 | -17.9% | 26.9% | ||
| Q2 24 | -34.6% | 26.3% | ||
| Q1 24 | -71.4% | 8.3% |
| Q4 25 | 0.0% | 2.6% | ||
| Q3 25 | 0.0% | 1.1% | ||
| Q2 25 | 0.0% | 1.1% | ||
| Q1 25 | 0.3% | 2.0% | ||
| Q4 24 | 0.0% | 1.6% | ||
| Q3 24 | 0.1% | 2.4% | ||
| Q2 24 | 0.1% | 1.4% | ||
| Q1 24 | 0.1% | 2.3% |
| Q4 25 | — | 2.81× | ||
| Q3 25 | — | 1.52× | ||
| Q2 25 | — | 1.48× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 1.85× | ||
| Q2 24 | — | 1.62× | ||
| Q1 24 | — | 0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
